HORMONE THERAPY WITH USAGE OF AGONISTS AND ANTAGONISTS OF LUTEINIZING HORMONE RELEASING HORMONE IN PATIENTS WITH PROSTATE CANCER
Prostate cancer (PC) is one of the most actual problems of modern oncourology. Hormone therapy (HT) using medical castration is the main method of treatment of patients with metastatic PC. HT with usage of the new class of drugs that block the receptors for luteinizing hormone releasing hormone (LHR...
Main Authors: | K. M. Nyushko, A. A. Krasheninnikov, M. P. Golovaschenko, A. D. Kaprin |
---|---|
Format: | Article |
Language: | Russian |
Published: |
QUASAR, LLC
2015-01-01
|
Series: | Issledovaniâ i Praktika v Medicine |
Subjects: | |
Online Access: | https://www.rpmj.ru/rpmj/article/view/20 |
Similar Items
-
Luteinizing hormone-releasing hormone antagonists in patients with prostate cancer. A standard approach and the results of innovative studies
by: K. M. Nyushko, et al.
Published: (2014-12-01) -
Luteinizing hormone-releasing hormone antagonists in patients with prostate cancer. A standard approach and the results of innovative studies
by: K. M. Nyushko, et al.
Published: (2014-12-01) -
Luteinizing hormone releasing hormone analogues in the treatment of patients with prostate cancer
by: B. Ya. Alexeev, et al.
Published: (2018-11-01) -
Luteinizing hormone changes in gonadotropin-releasing hormone antagonist protocol in in vitro fertilization cycles: A cross-sectional study
by: Batool Hosein Rashidi, et al.
Published: (2019-03-01) -
Diminished ovarian reserve predisposes to premature luteinizing hormone surges in gonadotropin-releasing hormone antagonist cycles in In vitro fertilization
by: Puneet Kaur Kochhar, et al.
Published: (2020-01-01)